Abstract
No public abstract is available from the verified source records.
Gael Dournes
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Impact of two years of treatment with elexacaftor/tezacaftor/ivacaftor on longitudinal changes in structural lung disease in people with cystic fibrosis: results from the RECOVER trial
10.1093/annalsats/aaoag021 · 2026
Fleischner Society: glossary of terms for thoracic imaging
10.1148/radiol.232558 · 2024
Quantitative CT evaluation of bronchiectasis improvement in cystic fibrosis after CFTR-modulator therapy
10.1148/ryct.250116 · 2025
Reversal of cylindrical bronchial dilatations in a subset of adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor
10.1183/13993003.01794-2023 · 2024
Radiographic outcomes in pediatric bronchiectasis and factors associated with reversibility
10.1164/rccm.202402-0411oc · 2024
Normative values for lung, bronchial sizes, and bronchus-artery ratios in chest CT scans: from infancy into young adulthood
10.1007/s00330-025-11367-w · 2025
No additional external references are available.